Anticancer effects of the metabolic products of the resveratrol analogue, DMU-212: Structural requirements for potency.

De Montfort University Open Research Archive

Show simple item record

dc.contributor.author Androutsopoulos, Vasilis
dc.contributor.author Ruparelia, K. C.
dc.contributor.author Papakyriakou, A.
dc.contributor.author Filippakis, H.
dc.contributor.author Tsatsakis, A. M.
dc.contributor.author Spandidos, D. A.
dc.date.accessioned 2011-06-23T09:04:35Z
dc.date.available 2011-06-23T09:04:35Z
dc.date.issued 2011
dc.identifier.citation Androutsopoulos, V.P. et al. (2011) Anticancer effects of the metabolic products of the resveratrol analogue, DMU-212: Structural requirements for potency. European Journal of Medicinal Chemistry, 46 (6), pp. 2586-2595 en
dc.identifier.issn 0223-5234
dc.identifier.uri http://hdl.handle.net/2086/5035
dc.language.iso en en
dc.publisher Elsevier en
dc.title Anticancer effects of the metabolic products of the resveratrol analogue, DMU-212: Structural requirements for potency. en
dc.type Article en
dc.identifier.doi http://dx.doi.org/10.1016/j.ejmech.2011.03.049
dc.researchgroup Chemistry for Health
dc.peerreviewed Yes en


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record